Trial Profile
A double-blind, randomised, multi-centre dose-finding study to investigate the effect of BAL8557 in patients with esophageal candidiasis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2015
Price :
$35
*
At a glance
- Drugs Isavuconazonium (Primary) ; Fluconazole
- Indications Candidiasis
- Focus Therapeutic Use
- 11 Mar 2015 New trial record